<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39420039</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Nationwide Cohort observational study on the safety and efficacy of COVID-19 vaccination in patients with Moyamoya disease.</ArticleTitle><Pagination><StartPage>24400</StartPage><MedlinePgn>24400</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24400</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-73940-5</ELocationID><Abstract><AbstractText>The safety and efficacy of coronavirus disease 2019 (COVID-19) vaccination in patients diagnosed with Moyamoya disease (MMD) have not been established. Using National Health Insurance Service data, this study analyzed the occurrence of stroke-related events and mortality following COVID-19 vaccination among patients diagnosed with MMD from 2008 to 2020. Among 10,297 MMD patients, 296 (2.9%) experienced events and 175 (1.7%) died in 2021. Significant risk factors for events included ages 50-59 (Odds Ratio [OR] 3.29; P = 0.022) and 60 or above (OR 5.20; P = 0.001) (reference group: age in 20s), low BMI (OR 2.00; P = 0.011), previous stroke (OR 1.96; P &lt; 0.001), and COVID-19 infection (OR 2.28; P = 0.034). Female (OR 0.64 [95% CI 0.50-0.82]; p = 0.011), revascularization surgery (RS) (OR 0.38 [95% CI 0.21-0.70]; p &lt; 0.001), and vaccination (OR 0.17 [95% CI 0.13-0.22]; p &lt; 0.001) were associated with reduced odds of stroke-related events. For mortality, significant risks were age over 60 (OR 7.09; P = 0.008), low BMI (OR 3.87; P = 0.001), and prior stroke (OR 1.74; p = 0.004), while being female, RS (OR 0.41; P = 0.022), and vaccination (OR 0.12; P &lt; 0.001) were associated with a lower frequency of mortality. mRNA vaccines were associated with a significantly lower incidence of events, mortality, and COVID-19 infections compared to vector vaccines. COVID-19 vaccination is linked to reduced stroke-related events and mortality in MMD patients, with mRNA vaccines showing a significantly lower incidence compared to vector vaccines. COVID-19 infection raises the risk of events, underscoring the benefit of vaccination.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Byoun</LastName><ForeName>Hyoung Soo</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Si Un</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea. nsmidget@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Won</LastName><ForeName>Yu Deok</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri-si, Korea. hidma823@hanmail.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Tae Won</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Hyo</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young-Deok</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ban</LastName><ForeName>Seung Pil</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang</LastName><ForeName>Jae Seung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>O-Ki</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Chang Wan</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009072" MajorTopicYN="Y">Moyamoya Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease</Keyword><Keyword MajorTopicYN="N">Moyamoya disease</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39420039</ArticleId><ArticleId IdType="pmc">PMC11487014</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-73940-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-73940-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kolahchi, Z., Khanmirzaei, M. &amp; Mowla, A. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; A systematic review. J. Neurol. Sci.439, 120327. 10.1016/j.jns.2022.120327 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212261</ArticleId><ArticleId IdType="pubmed">35752132</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimou, L. et al. Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: A systematic review and meta-analysis. J. Neurol.269, 3413–3419. 10.1007/s00415-022-11101-2 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990450</ArticleId><ArticleId IdType="pubmed">35394172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbour, P. et al. Characteristics of a COVID-19 cohort with large vessel occlusion: A multicenter international study. Neurosurgery90, 725–733. 10.1227/neu.0000000000001902 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514728</ArticleId><ArticleId IdType="pubmed">35238817</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. et al. Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study. Stroke Vasc. Neurol.5, 279–284. 10.1136/svn-2020-000431 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi, S. et al. Emergent large vessel occlusion stroke during New York City’s COVID-19 outbreak: Clinical characteristics and paraclinical findings. Stroke51, 2656–2663. 10.1161/STROKEAHA.120.030397 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434004</ArticleId><ArticleId IdType="pubmed">32755349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni, S., de Groot, R., Bell, S. &amp; Markus, H. S. Stroke in COVID-19: A systematic review and meta-analysis. Int. J. Stroke16, 137–149. 10.1177/1747493020972922 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, B. H. &amp; Yoo, M. C. Intracranial hemorrhage due to potential rupture of an arteriovenous malformation after BNT162b2 COVID-19 mRNA vaccination in a young korean woman: Case report. Vaccines (Basel)10.3390/vaccines10030362 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8953327</ArticleId><ArticleId IdType="pubmed">35334996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn, I. M. et al. Incidence, prevalence, and survival of moyamoya disease in Korea: A nationwide, population-based study. Stroke45, 1090–1095. 10.1161/STROKEAHA.113.004273 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24595588</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, S., Guo, Z. N., Shi, M., Yang, Y. &amp; Rao, M. Etiology and pathogenesis of Moyamoya disease: An update on disease prevalence. Int. J. Stroke12, 246–253. 10.1177/1747493017694393 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28381201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriyama, S. et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: Findings from a nationwide epidemiological survey. Stroke39, 42–47. 10.1161/STROKEAHA.107.490714 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18048855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H., Zheng, L. &amp; Feng, L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp. Ther. Med.17, 1977–1984. 10.3892/etm.2019.7198 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6395994</ArticleId><ArticleId IdType="pubmed">30867689</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki, J. &amp; Takaku, A. Cerebrovascular, “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol.20, 288–299. 10.1001/archneur.1969.00480090076012 (1969).</Citation><ArticleIdList><ArticleId IdType="pubmed">5775283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, W. S. et al. The natural clinical course of hemodynamically stable adult moyamoya disease. J. Neurosurg.122, 82–89. 10.3171/2014.9.JNS132281 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25361479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallemeier, C. L. et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke37, 1490–1496. 10.1161/01.STR.0000221787.70503.ca (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16645133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, E., Saeki, N., Oishi, H., Hirai, S. &amp; Yamaura, A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J. Neurosurg.93, 976–980. 10.3171/jns.2000.93.6.0976 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11117870</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto, S. et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: Results of the Japan Adult Moyamoya Trial. Stroke45, 1415–1421. 10.1161/STROKEAHA.113.004386 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24668203</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka, M. et al. High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery52, 1049–1054; discussion 1054–1045 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12699546</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, J. K. et al. Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in Korea. J. Korean Med. Sci.36, e223. 10.3346/jkms.2021.36.e223 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352786</ArticleId><ArticleId IdType="pubmed">34402235</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama, R. et al. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: A case report. Acta Neurochir. (Wien)164, 543–547. 10.1007/s00701-021-05038-0 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8594320</ArticleId><ArticleId IdType="pubmed">34783899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. H. et al. Clinical outcomes of clipping and coiling in elderly patients with unruptured cerebral aneurysms: A national cohort study in Korea. J. Korean Med. Sci.36, e178. 10.3346/jkms.2021.36.e178 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258241</ArticleId><ArticleId IdType="pubmed">34227262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. U. et al. Trends in the incidence and treatment of cerebrovascular diseases in Korea: Part I. Intracranial aneurysm, intracerebral hemorrhage, and arteriovenous malformation. J. Korean Neurosurg. Soc.63, 56–68. 10.3340/jkns.2018.0179 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6952728</ArticleId><ArticleId IdType="pubmed">31064041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. U. et al. Trends in the incidence and treatment of cerebrovascular diseases in Korea : Part II. Cerebral infarction, cerebral arterial stenosis, and moyamoya disease. J. Korean Neurosurg. Soc.63, 69–79. 10.3340/jkns.2018.0182 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6952727</ArticleId><ArticleId IdType="pubmed">31064040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, B. G. et al. Clinical outcomes of coil embolization for unruptured intracranial aneurysms categorized by region and hospital size: A nationwide cohort study in Korea. J. Korean Neurosurg. Soc.66, 690–702. 10.3340/jkns.2023.0033 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10641419</ArticleId><ArticleId IdType="pubmed">37661089</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim, H. S. et al. Optimal target blood pressure for the primary prevention of hemorrhagic stroke: A nationwide observational study. Front. Neurol.14, 1268542. 10.3389/fneur.2023.1268542 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10593468</ArticleId><ArticleId IdType="pubmed">37877030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, S. I. et al. Optimal blood pressure for stroke prevention in healthy adults below 65 years: A nationwide 10-year observational study. J. Clin. Neurosci.122, 44–52. 10.1016/j.jocn.2024.03.004 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38461741</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou, M. I. et al. Acute arterial ischemic stroke following COVID-19 vaccination: A systematic review and meta-analysis. Neurology99, e1465–e1474. 10.1212/WNL.0000000000200996 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36002319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakovan, M., Ghorbani Shirkouhi, S., Zarei, M. &amp; Andalib, S. Stroke associated with COVID-19 vaccines. J. Stroke Cerebrovasc. Dis.31, 106440. 10.1016/j.jstrokecerebrovasdis.2022.106440 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894799</ArticleId><ArticleId IdType="pubmed">35339857</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J., Cao, F., Luo, C., Guo, Y. &amp; Yan, J. stroke following coronavirus disease 2019 vaccination: Evidence based on different designs of real-world studies. J. Infect. Dis.228, 1336–1346. 10.1093/infdis/jiad306 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37536364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed, I. et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum. Vaccin. Immunother.18, 2027160. 10.1080/21645515.2022.2027160 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani, K. et al. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis. Front. Public Health10, 873596. 10.3389/fpubh.2022.873596 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9459165</ArticleId><ArticleId IdType="pubmed">36091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, N. et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir. Med.11, 439–452. 10.1016/S2213-2600(23)00015-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917454</ArticleId><ArticleId IdType="pubmed">36780914</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, H., Tang, X., Song, Y., Liu, P. &amp; Chen, Y. Influence of COVID-19 on cerebrovascular disease and its possible mechanism. Neuropsychiatr. Dis. Treat.16, 1359–1367. 10.2147/NDT.S251173 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266513</ArticleId><ArticleId IdType="pubmed">32547039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweid, A. et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int. J. Stroke15, 733–742. 10.1177/1747493020937189 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534206</ArticleId><ArticleId IdType="pubmed">32501751</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahab, F. et al. Factors associated with stroke after COVID-19 vaccination: A statewide analysis. Front. Neurol.14, 1199745. 10.3389/fneur.2023.1199745 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337778</ArticleId><ArticleId IdType="pubmed">37448752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano, Y. et al. Association between the onset pattern of adult Moyamoya disease and risk factors for stroke. Stroke51, 3124–3128. 10.1161/STROKEAHA.120.030653 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32867597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, P. et al. Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study. Stroke51, 2472–2479. 10.1161/STROKEAHA.120.030027 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32640948</ArticleId></ArticleIdList></Reference><Reference><Citation>Church, E. W. et al. Clinical course of unilateral moyamoya disease. Neurosurgery87, 1262–1268. 10.1093/neuros/nyaa284 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32710766</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, H. et al. Age- and sex-associated impacts of body mass index on stroke type risk: A 27-year prospective cohort study in a low-income population in China. Front. Neurol.10, 456. 10.3389/fneur.2019.00456 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6504695</ArticleId><ArticleId IdType="pubmed">31118920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurth, T. et al. Body mass index and the risk of stroke in men. Arch Intern. Med.162, 2557–2562. 10.1001/archinte.162.22.2557 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12456227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiozawa, M. et al. Association of body mass index with ischemic and hemorrhagic stroke. Nutrients10.3390/nu13072343 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308685</ArticleId><ArticleId IdType="pubmed">34371853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon, J. P. et al. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J. Neurosurg.128, 793–799. 10.3171/2016.11.JNS161688 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28474994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, T. et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J. Neurosurg.124, 1788–1793. 10.3171/2015.6.JNS151105 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26636391</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, H. et al. Association of bypass surgery and mortality in moyamoya disease. J. Am. Heart Assoc.12, e030834. 10.1161/JAHA.123.030834 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10727291</ArticleId><ArticleId IdType="pubmed">37947101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>